Voyager Therapeutics Inc.

NASDAQ: VYGR · Real-Time Price · USD
3.73
0.01 (0.27%)
At close: Aug 15, 2025, 3:59 PM
3.77
0.83%
After-hours: Aug 15, 2025, 07:35 PM EDT

Voyager Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
71.37M 68.8M 98.96M 117.43M
Short-Term Investments
195.32M 162.07M 19.89M 15.11M
Long-Term Investments
65.7M 1.59M 1.51M 1.78M
Other Long-Term Assets
2.87M n/a n/a n/a
Receivables
4.49M 84.45M 639K 748K
Inventory
n/a n/a 779K 1.71M
Other Current Assets
2.87M 2.63M 4.23M 1.7M
Total Current Assets
276.81M 319.68M 124.5M 136.7M
Property-Plant & Equipment
47.66M 30M 33.34M 55.38M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
116.24M 31.6M 34.86M 57.16M
Total Assets
393.05M 351.28M 159.36M 193.85M
Account Payables
4M 1.6M 2.57M 574K
Deferred Revenue
24.39M 42.88M 65.83M 42.1M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
6.75M 10.21M 3.26M 5.93M
Total Current Liabilities
49.79M 64.51M 72.59M 50.98M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
1M 1M 1M 1M
Total Long-Term Liabilities
43.5M 50.45M 27.75M 47.82M
Total Liabilities
93.29M 114.96M 100.34M 98.8M
Total Debt
43.73M 20.29M 23.13M 44.18M
Common Stock
55K 44K 38K 38K
Retained Earnings
-326.18M -261.18M -393.51M -347.1M
Comprehensive Income
-407K -48K -219K -138K
Shareholders Equity
299.76M 236.32M 59.02M 95.06M
Total Investments
261.02M 163.67M 19.89M 15.11M